 9 No 13.24 net shares | 76.0¢ / 99.1¢ | -$10.1 (-100.0%) | $6.56 6.62 shares | Apr 26, 2026 8:44 PM | |
 Pass 6-9% No 12.90 net shares | 77.0¢ / 99.7¢ | -$9.93 (-100.0%) | $6.43 6.45 shares | Apr 21, 2026 1:46 AM | |
6 No 12.44 net shares | 80.3¢ / 99.9¢ | -$9.99 (-100.0%) | $6.21 6.22 shares | Apr 25, 2026 1:08 AM | |
7 No 12.39 net shares | 80.6¢ / 99.9¢ | -$9.98 (-100.0%) | $6.19 6.19 shares | Apr 25, 2026 9:33 AM | |
 The Alternative No 5.39 net shares | 92.6¢ / 97.5¢ | -$4.99 (-100.0%) | $5.26 5.39 shares | Mar 23, 2026 6:35 PM | |
>9 No 10.40 net shares | 76.0¢ / 99.9¢ | -$7.9 (-100.0%) | $5.19 5.20 shares | Apr 25, 2026 2:41 PM | |
 FDA approves Sanofi’s Subcutaneous Sarclisa? Yes 5.81 net shares | 86.0¢ / 1.0¢ | -$5 (-100.0%) | $0.06 5.81 shares | Apr 22, 2026 10:55 AM | |
8 No 12.40 net shares | 80.6¢ / 0.1¢ | -$9.99 (-100.0%) | $0.01 6.20 shares | Apr 25, 2026 6:25 AM |
